Shareholders of the former Bradley Pharmaceuticals Inc. have asked a federal judge to approve a $3.5 million settlement that closes the book on securities litigation that began in 2005.
General Motors Corp. has lost a bid to keep under wraps court transcripts that the automaker claims could damage its reputation by revealing a preliminary finding that it fraudulently concealed the testing of an alternative car design from evidence in a motor vehicle liability case.
The debtor-in-possession financier for LandSource Communities Development LLC is protesting the most recent fee application brought by Pachulski Stang Ziehl & Jones LLP, arguing that the price tag submitted by the unsecured creditors' counsel exceeds the limit the DIP order set.
Schering Corp. has been hit with a lawsuit accusing the drugmaker of reporting inflated prices for albuterol to Medicaid in violation of the False Claims Act and federal anti-kickback laws in order to boost its product over the competition.
A Las Vegas jury has found that MEI Inc.’s devices used in casino games infringed Japan Cash Machine Co. Ltd.’s patent and awarded the company more than $11.4 million in damages.
Sprint Nextel Corp. has agreed to pay $17.5 million to settle a class action lawsuit brought by customers who claim the communications company's flat-rate early termination fees violate state and federal laws.
Anderson Kill & Olick PC has combined with a 14-lawyer firm to bolster its insurance enforcement practice, and Nexsen Pruet is setting up shop in the capital city of North Carolina thanks to a key tie-up with a seven-lawyer firm.
A federal court has granted Johnson & Johnson summary judgment in a proposed collective action alleging that the company misclassified sales representatives as exempt from overtime pay in order to avoid fully compensating them for all the time they worked.
A renowned psychiatrist has agreed to halt his participation in several industry-funded clinical trials in the wake of allegations that he worked with Johnson & Johnson to create a research center that promoted the company's anti-psychotic drug Risperdal for use among children.
The U.S. Federal Trade Commission has allowed King Pharmaceuticals Inc. to complete its approximately $1.6 billion acquisition of rival Alpharma Inc., but it forced the sale of Alpharma’s long-acting opioid analgesic drug, Kadian, to alleviate competition concerns.
A judge has granted class status to a group of purchasers who sued health care giants Schering-Plough Corp. and Upsher-Smith Laboratories Inc. alleging an anti-competitive pact to keep generic versions of heart drug K-Dur 20 off the shelves.
Generic-drug maker Actavis Group has reached an agreement with the U.S. Food and Drug Administration to halt production at three of its U.S. subsidiary's plants until the facilities are upgraded to meet the agency's manufacturing regulations.
Barr Laboratories Inc. has agreed to take out a license to make a generic version of Warner Chilcott Ltd.'s chewable contraceptive Femcon Fe in order to resolve patent litigation surrounding the drug, the companies announced last week.
Teva Pharmaceutical Industries Ltd. has completed its $8.9 billion acquisition of rival Barr Pharmaceuticals Inc. after agreeing to sell competing products in 29 U.S. and 17 European markets for generic drugs.
A female engineer has filed a putative class action suit against Lockheed Martin Corp., accusing the defense contractor of discriminating against certain female employees by systematically passing them over for upper-level management positions.
After more than 150 years in the business, Thacher Proffitt & Wood LLP is closing up shop, ending months of speculation about the firm’s ability to weather the current economic storm.
Schering Corp., Sepracor Inc. and Dr. Reddy's Laboratories Ltd. have struck settlement deals that should resolve litigation and allow the India-based generics maker to enter the $362 million annual U.S. market for the allergy drug Clarinex in 2012, Dr. Reddy's said.
Abbott Laboratories lost a bid to dodge a $29.2 million damages tab when the court overseeing a suit brought by Church & Dwight Co. Inc. against Abbott over three patents related to home pregnancy tests rejected Abbott’s argument that the plaintiff wasn't entitled to damages because of the doctrine of laches.
A judge has denied class certification to the plaintiffs in two lawsuits filed against DuPont Co. over the release of a potentially hazardous substance into a New Jersey county’s water supply, but has offered the plaintiffs a chance to submit further briefings and file an amended request.
The troubled firm of Thacher Proffitt & Wood LLP, which last week began seeking a merger to avoid dissolution, has been selected by the U.S. Department of the Treasury to advise on the government's Wall Street bailout.